A9 Use of homeoboxA9 as a melasma or seborrheic keratosis distinguishing marker

The present invention relates to a composition for a marker to distinguishing melasma or lentigo, a composition and/or a kit for distinguishing melasma or lentigo, and a method for distinguishing and diagnosing melasma or lentigo using the composition, which can effectively distinguish, diagnose, an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEE, AI YOUNG, CHEONG, KYUNG AH
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a composition for a marker to distinguishing melasma or lentigo, a composition and/or a kit for distinguishing melasma or lentigo, and a method for distinguishing and diagnosing melasma or lentigo using the composition, which can effectively distinguish, diagnose, and predict melasma or lentigo in early stages. Melasma and lentigo are expected to be distinguished by the present invention, and the composition will be usefully used to develop a treatment agent for the melasma or lentigo by adjusting the expression and activity of Homeobox A9, which is a marker of the present invention. 본 발명은 기미 또는 검버섯을 조기에 효과적으로 구별 진단 및 예측할 수 있는 기미 또는 검버섯 구별 마커용 조성물, 기미 또는 검버섯 구별용 조성물 및/또는 키트, 상기 조성물을 이용한 기미 또는 검버섯 구별 진단 방법에 관한 것으로, 본 발명으로 기미 또는 검버섯의 구별이 가능할 것으로 기대되며, 본 발명의 마커인 호메오박스A9의 발현 및 활성을 조절하여 기미 또는 검버섯 치료제 개발에 유용하게 사용할 수 있을 것으로 기대된다.